Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: Prevalence and clinical outcome

Antiviral Therapy

Volumn 16, Issue 7, 2011, Pages 1103-1112

  D'Arminio Monforte, Antonella ^a   Cozzi Lepri, Alessandro ^b,c   Girardi, Enrico ^d   Castagna, Antonella ^e   Mussini, Cristina ^f   Di Giambenedetto, Simona ^g   Galli, Massimo ^h   Cassola, Giovanni ⁱ   Vullo, Vincenzo ^j   Quiros Roldan, Eugenia ^k   Lo Caputo, Sergio ^l   Antinori, Andrea ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ GALLIERA HOSPITAL   (Italy)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k UNIVERSITY OF BRESCIA   (Italy)

^l SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETIREMENT; UNEMPLOYMENT;

ADULT; AGE FACTORS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DELAYED DIAGNOSIS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; ITALY; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 80055083850     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1883     Document Type: Article

References (46)

1. + cell counts in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2003; 19:363-368.
2. Easterbrook PJ, Yu L, Goetghebeur E, Boag F, McLean K, Gazzard B. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS 2000; 14:561-571. (Pubitemid 30209699)
3. Girardi E, Aloisi M, Arici C, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36:951-959. (Pubitemid 38944091)
4. Mocroft A, Phillips A, Gatell J, et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370:407-413. (Pubitemid 47176633)
5. + cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis 2009; 48:787-794.
6. Egger M, May M, Chêne G, et al. Prognosis of HIV- 1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-129. (Pubitemid 34786200)
7. Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 2003; 163:2187-2195. (Pubitemid 37248783)
8. Smith CJ, Olsen C, Mocroft A, et al. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study. AIDS 2008; 22:47-56. (Pubitemid 350294877)
9. Curkendall SM, Richardson J, Emons M, Fisher A, Everhard F. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2007; 8:483-490. (Pubitemid 47616826)
10. Jericó C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005; 28:132-137. (Pubitemid 40095795)
11. Elzi L, Marzolini C, Furrer H, et al. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Arch Intern Med 2010; 170:57- 65.
12. Marks G, Crepaz N, Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447-1450. (Pubitemid 43948252)
13. Crepaz N, Marks G, Liau A, et al. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. AIDS 2009; 23:1617-1629.
14. Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008; 47:577- 584.
15. Krentz HB, Auld M, Gill M. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med 2004; 5:93-98. (Pubitemid 38404662)
16. Manavi K, McMillan A, Ogilvie M, Scott G. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS 2004; 15:811-814 (Pubitemid 40018705)
17. Gay CL, Napravnik S, Eron JJ. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS 2006; 20:775-778. (Pubitemid 43884306)
18. Sabin CA, Smith C, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004; 18:2145-2151. (Pubitemid 39463679)
19. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16:1945-1951.
20. Antinori A, Johnson M, Moreno S, Yazdanpanah Y, Rockstroh JK. Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation. Antivir Ther 2010; 15 Suppl 1:31-35.
21. Antinori A, Coenen T, Dedes N, et al. Late presentation of HIV infection: a consensus definition. HIV Medicine 2011; 12:61-64.
22. When To Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-1363.
23. Kitahata MM, Gange S, Abraham A, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360:1815-1826.
24. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. (Updated 10 January 2011. Accessed 3 November 2010.) Available from http://aidsinfo.nih.gov/ contentfiles/AdultandAdolescentGL.pdf
25. EACS. Guidelines for clinical management and treatment of HIV infected adults in Europe. (Accessed 3 November 2010.) Available from http://europeanaidsclinicalsociety. org/images/stories/EACS-Pdf/1-treatment-of- hiv-infected- adults.pdf
26. d'Arminio Monforte A, Lepri A, Rezza G, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS 2000; 14:499-507. (Pubitemid 30209692)
27. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
28. Wolbers M, Bucher H, Furrer H, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 2008; 9:397-405 (Pubitemid 352015643)
29. Delpierre C, Lauwers-Cances V, Pugliese P, et al. Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. Eur J Public Health 2008; 18:345-347. (Pubitemid 351786632)
30. Begovac J, Gedike K, Lukas D, Lepej S. Late presentation to care for HIV infection in Croatia and the effect of interventions during the Croatian Global Fund Project. AIDS Behav 2008; 12:S48-S53.
31. Sullivan AK, Curtis H, Sabin C, Johnson M. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005; 330:1301-1302. (Pubitemid 40813561)
32. Borghi V, Girardi E, Bellelli S, et al. Late presenters in an HIV surveillance system in Italy during the period 1992- 2006. J Acquir Immune Defic Syndr 2008; 49:282-286.
33. The UK Collaborative HIV Cohort (UK CHIC) Steering Committee. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010; 24:723-727.
34. Lanoy E, Mary-Krause M, Tattevin P, et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007; 12:89-96. (Pubitemid 46340430)
35. Quinn TC, Wawer M, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929. (Pubitemid 30177052)
36. Zolopa A, Andersen J, Powderly W, et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE 2009; 4:e5575.
37. Chadborn TR, Delpech V, Sabin C, Sinka K, Evans B. The late diagnosis and consequent short-term mortality of HIVinfected heterosexuals (England and Wales, 2000-2004). AIDS 2006; 20:2371-2379. (Pubitemid 44789540)
38. Chadborn TR, Baster K, Delpech V, et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 2005; 19:513-520. (Pubitemid 40515855)
39. Smit C, Hallett T, Lange J, Garnett G, de Wolf F. Late entry to HIV care limits the impact of anti-retroviral therapy in the Netherlands. PLoS One 2008; 3:e1949.
40. The antiretroviral therapy cohort collaboration (ART-CC). Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. AIDS 2009; 23:2199-2208.
41. 3. Antivir Ther 2009; 14:451-457.
42. Ray K, Gupta S, Bala M, Muralidhar S, Kumar J. CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients. Indian J Med Res 2006; 124:319-330. (Pubitemid 44734289)
43. + T lymphocytes and progression to AIDS in HIV-infected men: some observations. AIDS 1991; 5:213-215.
44. Chevret S, Roquin H, Ganne P, Lefrère J. Prognostic value of an elevated CD8 lymphocyte count in HIV infection. Results of a prospective study of 152 asymptomatic HIVpositive individuals. AIDS 1992; 6:1349-1352.
45. Reus S, Portilla J, Gimeno A, et al. Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy. Enferm Infecc Microbiol Clin 2004; 22:142-149. (Pubitemid 38541593)
46. Prosperi MCF, Cozzi-Lepri A, Castagna A, et al. The incidence of malignancies in HIV-infected patients and postic role of current CD4 cell count: evidence from a Italian study. Clin Infect Dis 2010; 50:1316-1321.